文献速递糖尿病

儿童1型糖尿病中预测性低血糖胰岛素暂停对低血糖的预防:一项随机对照试验

Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial.
PubMed 文献 · Diabetes Care · 2017-03-28

这项随机、两臂、平行、对照、两中心开放标签研究纳入100例1型糖尿病儿童和青少年,随机分为预测性低血糖管理(PLGM)开启组与关闭组,比较14天内传感器血糖低于65 mg/dL(3.6 mmol/L)的低血糖事件数。PLGM开启组低血糖事件数显著少于关闭组(均值±标准差 4.4±4.5 vs 7.4±6.3,P=0.008),但PLGM开启组高于140 mg/dL(7.8 mmol/L)的时间显著增加(P=0.0165)。

要点

  • PLGM开启组传感器血糖低于65 mg/dL的低血糖事件数显著少于关闭组(4.4±4.5 vs 7.4±6.3,P=0.008)。
  • 夜间(P=0.025)和日间(P=0.022)低血糖事件数在PLGM开启组均显著减少。
  • PLGM开启组高于140 mg/dL的时间显著增加(P=0.0165),无严重低血糖事件发生。

核心结论

  • 预测性低血糖胰岛素暂停与低血糖事件数显著减少相关,代价是中度高血糖时间增加,但年轻1型糖尿病患者无严重不良事件。

研究设计与样本

  • 随机、两臂、平行、对照、两中心开放标签研究,纳入100例糖化血红蛋白A1c≤10%(≤86 mmol/mol)且使用持续皮下胰岛素输注的1型糖尿病儿童和青少年。
  • 患者按1:1比例随机分配至PLGM功能开启组(PLGM ON)或对照组(PLGM OFF),均使用同类型传感器增强胰岛素泵,主要终点为14天研究治疗期间基于传感器血糖读数的低于65 mg/dL(3.6 mmol/L)的低血糖事件数,按意向治疗分析所有随机患者。

主要发现

  • PLGM开启组低于65 mg/dL(3.6 mmol/L)的低血糖事件数显著少于PLGM关闭组(均值±标准差 4.4±4.5 vs 7.4±6.3,P=0.008)。
  • 夜间低血糖事件数在PLGM开启组显著少于关闭组(P=0.025),日间亦显著少于关闭组(P=0.022)。
  • 无严重低血糖事件发生;PLGM开启组高于140 mg/dL(7.8 mmol/L)的时间显著增加(P=0.0165)。

关键数值与推荐

  • 主要终点:14天研究治疗期间传感器血糖低于65 mg/dL(3.6 mmol/L)的低血糖事件数,PLGM开启组均值±标准差 4.4±4.5 vs PLGM关闭组 7.4±6.3,P=0.008。
  • 夜间低血糖事件数比较P=0.025,日间低血糖事件数比较P=0.022。
  • 高于140 mg/dL(7.8 mmol/L)的时间在PLGM开启组显著增加,P=0.0165。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether predictive low glucose management (PLGM) of the MiniMed 640G system significantly reduces the rate of hypoglycemia compared with the sensor-augmented insulin pump in children with type 1 diabetes. RESEARCH DESIGN AND METHODS: This randomized, two-arm, parallel, controlled, two-center open-label study included 100 children and adolescents with type 1 diabetes and glycated hemoglobin A1c ≤10% (≤86 mmol/mol) and using continuous subcutaneous insulin infusion. Patients were randomly assigned to either an intervention group with PLGM features enabled (PLGM ON) or a control group (PLGM OFF), in a 1:1 ratio, all using the same type of sensor-augmented insulin pump. The primary end point was the number of hypoglycemic events below 65 mg/dL (3.6 mmol/L), based on sensor glucose readings, during a 14-day study treatment. The analysis was performed by intention to treat for all randomized patients. RESULTS: The number of hypoglycemic events below 65 mg/dL (3.6 mmol/L) was significantly smaller in the PLGM ON compared with the PLGM OFF group (mean ± SD 4.4 ± 4.5 and 7.4 ± 6.3, respectively; P = 0.008). This was also true when calculated separately for night (P = 0.025) and day (P = 0.022). No severe hypoglycemic events occurred; however, there was a significant increase in time spent above 140 mg/dL (7.8 mmol/L) in the PLGM ON group (P = 0.0165). CONCLUSIONS: The PLGM insulin suspension was associated with a significantly reduced number of hypoglycemic events. Although this was achieved at the expense of increased time in moderate hyperglycemia, there were no serious adverse effects in young patients with type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Battelino T, Nimri R, Dovc K, et al. Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2017. PMID: 28351897. doi:10.2337/dc16-2584

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。